NCT00606112View on ClinicalTrials.gov

A Single Dose, Tolerance and Pharmacokinetic Study in Obese or Overweight Type 2 Diabetic Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

June 30, 2008

Study Completion Date

April 30, 2009

Conditions
Diabetes MellitusObesity
Interventions
DRUG

Trodusquemine (MSI-1436)

A single dose will be administered on Day 0. Doses are 3mg/m2 in cohort 1, 6mg/m2 in cohort 2, 10mg/m2 in cohort 3 and 15mg/m2 in cohort 4/

Trial Locations (1)

78229

dgd Research, San Antonio

Sponsors
All Listed Sponsors
lead

Genaera Corporation

INDUSTRY